Cover Image

Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study

Background and purpose: To compare the efficacy, safety, and immunogenicity of recombinant insulin aspart 100 U/mL manufactured by BioGenomics Limited (BGL-ASP) with innovator NovoRapid® in type 2 diabetes mellitus patients (T2 DM). Experimental approach: This was a multicenter, open-label, randomiz...

Full description

Saved in:
Bibliographic Details
Main Authors: Sneha A. Dongre (Author), Gauri A. Kulkarni (Author), Akshay Mishra (Author), Rutuja B. Deshmane (Author), Nameeta Sonar (Author), Kanica Yashi (Author), Damodar Thapa (Author), Nikhil Ghade (Author), Sachin M. Kadoo (Author), Archana R. Krishnan (Author), Sanjay M. Sonar (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2024-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items